Indoles having anti-diabetic activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S484000

Reexamination Certificate

active

07345085

ABSTRACT:
Indoles having aryloxyalkanoic acid substituents or arylalkanoic acid substituents are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

REFERENCES:
patent: 5482960 (1996-01-01), Berryman et al.
patent: 5686481 (1997-11-01), Elliott et al.
patent: 7186746 (2007-03-01), Acton et al.
patent: 1 424 325 (2004-06-01), None
patent: WO 98/08818 (1998-03-01), None
patent: WO 99/43651 (1999-09-01), None
patent: WO 99/43654 (1999-09-01), None
patent: WO 99/43672 (1999-09-01), None
patent: WO 00/35886 (2000-06-01), None
patent: WO 01 30343 (2001-05-01), None
patent: WO 02 08188 (2002-01-01), None
patent: WO 02/30895 (2002-04-01), None
patent: WO 2004/006920 (2004-01-01), None
Expert Opin. Emerging Drugs, 2006, 11(3), 379-401.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Indoles having anti-diabetic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indoles having anti-diabetic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoles having anti-diabetic activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3970416

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.